NCT00460785View on ClinicalTrials.gov

Bioequivalence Trial of a New Opioid Combination Compared to Reference

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

March 31, 2007

Conditions
Healthy
Interventions
DRUG

Opioid

Sponsors

Lead Sponsor

Grünenthal GmbH
All Listed Sponsors
lead

Grünenthal GmbH

INDUSTRY

NCT00460785 - Bioequivalence Trial of a New Opioid Combination Compared to Reference | Biotech Hunter | Biotech Hunter